NCT00356993

Brief Summary

20% of Ontarians smoke. There was a decline in smoking prevalence from 1995 but it has remained unchanged since 2002. This rate of smoking cessation has not kept up with the rest of Canada. A new strategy is necessary to increase the number of smokers making quit attempts and to increase the odds of quitting long term.The goal of this study is to evaluate the methods and effectiveness of providing nicotine replacement (NRT) to Ontario smokers. The study will develop an evidence-based protocol for providing NRT, provide faculty development on combining pharmacotherapy with behavioural interventions and will provide an evaluation framework to inform future coverage models.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,009

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2005

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2005

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

July 25, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 27, 2006

Completed
11.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2018

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

May 2, 2019

Completed
Last Updated

November 30, 2021

Status Verified

November 1, 2021

Enrollment Period

12.5 years

First QC Date

July 25, 2006

Results QC Date

August 17, 2018

Last Update Submit

November 25, 2021

Conditions

Keywords

nicotine replacement therapysmoking cessation

Outcome Measures

Primary Outcomes (1)

  • Count of Participants Not Smoking

    7-day point prevalence of abstinence at 6 months post treatment

    6 months post treatment

Secondary Outcomes (1)

  • Count of Participants Not Smoking

    12 months post treatment

Study Arms (1)

NRT + Behavioural Support

EXPERIMENTAL

Nicotine Replacement Therapy plus Behavioural Intervention

Drug: Nicotine Replacement TherapyBehavioral: behavioural intervention

Interventions

transdermal nicotine patch, nicotine gum, nicotine inhaler, nicotine lozenge

Also known as: transdermal nicotine patch, nicotine gum, nicotine inhaler, nicotine lozenge
NRT + Behavioural Support

Smoking cessation counselling, relapse prevention strategies

NRT + Behavioural Support

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects must be Ontario residents
  • Older than or equal to 18 years of age
  • Current daily smokers who smoke \>10 cigarettes per day
  • Smoked more than 100 cigarettes in their lifetime

You may not qualify if:

  • Current treatment with Varenicline
  • Allergic to adhesive
  • Intolerant to Nicotine Replacement Therapy
  • Medical contraindications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Addiction and Mental Health

Toronto, Ontario, M5S 2S1, Canada

Location

Related Links

MeSH Terms

Conditions

SmokingSmoking Cessation

Interventions

Nicotine Replacement TherapyTobacco Use Cessation DevicesNicotine Chewing GumNicotine

Condition Hierarchy (Ancestors)

BehaviorHealth Behavior

Intervention Hierarchy (Ancestors)

Drug TherapyTherapeuticsChewing GumPlant GumsBiopolymersPolymersMacromolecular SubstancesPolysaccharidesCarbohydratesCandyFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesSolanaceous AlkaloidsAlkaloidsHeterocyclic CompoundsPyridinesHeterocyclic Compounds, 1-Ring

Results Point of Contact

Title
Dr. Peter Selby
Organization
Addictions Program

Study Officials

  • Peter Selby, MD, MHSc

    Centre for Addiction and Mental Health

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Addictions Program

Study Record Dates

First Submitted

July 25, 2006

First Posted

July 27, 2006

Study Start

October 1, 2005

Primary Completion

March 30, 2018

Study Completion

March 30, 2018

Last Updated

November 30, 2021

Results First Posted

May 2, 2019

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations